Marty Makary

What's this administration's view on these AI tools?

Are they a supplement, a replacement?

Are they a supplement, a replacement?

And then how do we allow them to proliferate if they're good?

And then how do we allow them to proliferate if they're good?

And do they need to be regulated?

And do they need to be regulated?

Or are we going to end up regulating these AI doctors, these AI medical systems?

Or are we going to end up regulating these AI doctors, these AI medical systems?

So wearables, meaning heart rate, blood pressure, glucose monitors, those sorts of things get deregulated, more accessible, lower price, and so on?

So wearables, meaning heart rate, blood pressure, glucose monitors, those sorts of things get deregulated, more accessible, lower price, and so on?

Got it.

Got it.

Okay.

Okay.

One other area I've spent some time in in my career is in alternative proteins.

One other area I've spent some time in in my career is in alternative proteins.

And this is something that your agency regulates.

And this is something that your agency regulates.

So making animal proteins, eggs and cheese and milk and so on using bacterial or yeast cells rather than making them from the animal, you get the same protein, you just use a different mechanism of making that protein, or cellular meat where they're actually growing the chicken breast or growing the beef.